Completed PHASE3 INTERVENTIONAL 2-arm NCT05598242

Amniotic Membrane Treatment for Hyposecretory Dry Eye

Sponsor: Hospital Nacional Profesor Alejandro Posadas

Conditions Dry Eye Syndromes Sjogren Syndrome With Keratoconjunctivitis

Interventions Amniotic membrane extract eye drops (AMEED)

Updated 3 times since 2022 Last updated: Oct 24, 2022 Started: Feb 1, 2019 Primary completion: Sep 1, 2019 Completion: Dec 15, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05598242, this PHASE3 trial focuses on Dry Eye Syndromes and Sjogren Syndrome With Keratoconjunctivitis and remains completed. Sponsored by Hospital Nacional Profesor Alejandro Posadas, it has been updated 3 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Nov 2022 — Jul 2024 [monthly]

Completed PHASE3

First recorded

Feb 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Nacional Profesor Alejandro Posadas

Data source: Hospital Nacional Profesor Alejandro Posadas

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• El Palomar, Argentina